Skip header and navigation

Refine By

511 records – page 1 of 52.

The 1 alpha-hydroxylase locus is not linked to calcium stone formation or calciuric phenotypes in French-Canadian families.

https://arctichealth.org/en/permalink/ahliterature206213
Source
J Am Soc Nephrol. 1998 Mar;9(3):425-32
Publication Type
Article
Date
Mar-1998
Author
P. Scott
D. Ouimet
Y. Proulx
M L Trouvé
G. Guay
B. Gagnon
L. Valiquette
A. Bonnardeaux
Author Affiliation
Service de Néphrologie, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada.
Source
J Am Soc Nephrol. 1998 Mar;9(3):425-32
Date
Mar-1998
Language
English
Publication Type
Article
Keywords
25-Hydroxyvitamin D3 1-alpha-Hydroxylase - genetics - metabolism
Adult
Calcium - urine
Canada
European Continental Ancestry Group - genetics
Family Health
Female
France - ethnology
Genetic Linkage
Genetic Markers - genetics
Humans
Kidney Calculi - enzymology - genetics
Male
Middle Aged
Nuclear Family
Pedigree
Phenotype
Vitamin D - blood
Abstract
Calcium urolithiasis is often associated with increased intestinal absorption and urine excretion of calcium, and has been suggested to result from increased vitamin D production. The role of the enzyme 1 alpha-hydroxylase, the rate-limiting step in active vitamin D production, was evaluated in 36 families, including 28 sibships with at least a pair of affected sibs, using qualitative and quantitative trait linkage analyses. Sibs with a verified calcium urolithiasis passage (n = 117) had higher 24-h calciuria (P = 0.03), oxaluria (P = 0.02), fasting and postcalcium loading urine calcium/creatinine (Ca/cr) ratios (P = 0.008 and P = 0.002, respectively), and serum 1,25(OH)2 vitamin D levels (P = 0.02) compared with nonstone-forming sibs (n = 120). Markers from a 9-centiMorgan interval encompassing the VDD1 locus on chromosome 12q13-14 (putative 1 alpha-hydroxylase) were analyzed in 28 sibships (146 sib pairs) of single and recurrent stone formers and in 14 sibships (65 sib pairs) with recurrent-only (> or = 3 episodes) stone-forming sibs. Two-point and multipoint analyses did not reveal excess in alleles shared among affected sibs at the VDD1 locus. Linkage of stone formation to the VDD1 locus could be excluded, respectively, with a lambda d of 2.0 (single and recurrent stone formers) and 3.25 (recurrent stone formers). Quantitative trait analyses revealed no evidence for linkage to 24-h calciuria and oxaluria, serum 1,25(OH)2 vitamin D levels, and Ca/cr ratios. This study shows absence of linkage of the putative 1 alpha-hydroxylase locus to calcium stone formation or to quantitative traits associated with idiopathic hypercalciuria. In addition, there is coaggregation of calciuric and oxaluric phenotypes with stone formation.
PubMed ID
9513904 View in PubMed
Less detail

ABCG2 polymorphism markedly affects the pharmacokinetics of atorvastatin and rosuvastatin.

https://arctichealth.org/en/permalink/ahliterature150732
Source
Clin Pharmacol Ther. 2009 Aug;86(2):197-203
Publication Type
Article
Date
Aug-2009
Author
J E Keskitalo
O. Zolk
M F Fromm
K J Kurkinen
P J Neuvonen
M. Niemi
Author Affiliation
Department of Clinical Pharmacology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Source
Clin Pharmacol Ther. 2009 Aug;86(2):197-203
Date
Aug-2009
Language
English
Publication Type
Article
Keywords
ATP-Binding Cassette Transporters - genetics
Adult
Anticholesteremic Agents - pharmacokinetics
Area Under Curve
Cross-Over Studies
Drug Resistance, Multiple
European Continental Ancestry Group - genetics
Female
Finland
Fluorobenzenes - administration & dosage - blood - pharmacokinetics - urine
Genotype
Heptanoic Acids - administration & dosage - blood - pharmacokinetics - urine
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacokinetics
Linear Models
Male
Neoplasm Proteins - genetics
Polymorphism, Single Nucleotide
Pyrimidines - administration & dosage - blood - pharmacokinetics - urine
Pyrroles - administration & dosage - blood - pharmacokinetics - urine
Reference Values
Sulfonamides - administration & dosage - blood - pharmacokinetics - urine
Abstract
The ABCG2 c.421C>A single-nucleotide polymorphism (SNP) was determined in 660 healthy Finnish volunteers, of whom 32 participated in a pharmacokinetic crossover study involving the administration of 20 mg atorvastatin and rosuvastatin. The frequency of the c.421A variant allele was 9.5% (95% confidence interval 8.1-11.3%). Subjects with the c.421AA genotype (n = 4) had a 72% larger mean area under the plasma atorvastatin concentration-time curve from time 0 to infinity (AUC(0-infinity)) than individuals with the c.421CC genotype had (n = 16; P = 0.049). In participants with the c.421AA genotype, the rosuvastatin AUC(0-infinity) was 100% greater than in those with c.421CA (n = 12) and 144% greater than in those with the c.421CC genotype. Also, those with the c.421AA genotype showed peak plasma rosuvastatin concentrations 108% higher than those in the c.421CA genotype group and 131% higher than those in the c.421CC genotype group (P
PubMed ID
19474787 View in PubMed
Less detail

Absence of linkage of phonological coding dyslexia to chromosome 6p23-p21.3 in a large family data set.

https://arctichealth.org/en/permalink/ahliterature204108
Source
Am J Hum Genet. 1998 Nov;63(5):1448-56
Publication Type
Article
Date
Nov-1998
Author
L L Field
B J Kaplan
Author Affiliation
Department of Medical Genetics, Faculty of Medicine, Alberta Children's Hospital, University of Calgary, Calgry, Alberta, Canada. field@ucalgary.ca
Source
Am J Hum Genet. 1998 Nov;63(5):1448-56
Date
Nov-1998
Language
English
Publication Type
Article
Keywords
African Continental Ancestry Group - genetics
Alberta
Alleles
Auditory Perception
Child
Chromosome Mapping
Chromosomes, Human, Pair 6
Dyslexia - genetics - physiopathology
Europe - ethnology
European Continental Ancestry Group - genetics
Gene Frequency
Genetic Linkage
Genetic markers
Genotype
Humans
Lod Score
Nuclear Family
Abstract
Previous studies have suggested that a locus predisposing to specific reading disability (dyslexia) resides on chromosome 6p23-p21.3. We investigated 79 families having at least two siblings affected with phonological coding dyslexia, the most common form of reading disability (617 people genotyped, 294 affected), and we tested for linkage with the genetic markers reported to be linked to dyslexia in those studies. No evidence for linkage was found by LOD score analysis or affected-sib-pair methods. However, using the affected-pedigree-member (APM) method, we detected significant evidence for linkage and/or association with some markers when we used published allele frequencies with weighting of rarer alleles. APM results were not significant when we used marker allele frequencies estimated from parents. Furthermore, results were not significant with the more robust SIMIBD method using either published or parental marker frequencies. Finally, family-based association analysis using the AFBAC program showed no evidence for association with any marker. We conclude that the APM method should be used only with extreme caution, because it appears to have generated false-positive results. In summary, using a large data set with high power to detect linkage, we were unable to find evidence for linkage or association between phonological coding dyslexia and chromosome 6p markers.
Notes
Cites: Am J Hum Genet. 1997 Jan;60(1):27-398981944
Cites: Am J Hum Genet. 1996 Apr;58(4):892-58644756
Cites: Acta Psychiatr Neurol Suppl. 1950;65:1-28714846691
Cites: Dev Med Child Neurol. 1973 Apr;15(2):184-74697752
Cites: Ann Hum Genet. 1976 Jul;40(1):1-23962317
Cites: Behav Genet. 1980 Jan;10(1):9-307425998
Cites: Science. 1983 Mar 18;219(4590):1345-76828864
Cites: Am J Hum Genet. 1985 May;37(3):482-983859205
Cites: Clin Genet. 1987 Aug;32(2):118-93652490
Cites: Nature. 1987 Oct 8-14;329(6139):537-93657975
Cites: Am J Hum Genet. 1988 Feb;42(2):315-263422543
Cites: Nucleic Acids Res. 1988 Feb 11;16(3):12153344216
Cites: Am J Hum Genet. 1989 Mar;44(3):388-962916582
Cites: Am J Hum Genet. 1989 Apr;44(4):543-512929597
Cites: J Am Acad Child Adolesc Psychiatry. 1989 May;28(3):326-312661524
Cites: J Learn Disabil. 1989 Jun-Jul;22(6):339-482738467
Cites: J Am Acad Child Adolesc Psychiatry. 1990 Mar;29(2):204-131969860
Cites: Arch Neurol. 1990 Aug;47(8):919-262375699
Cites: Nucleic Acids Res. 1990 Jul 25;18(14):43012377495
Cites: Arch Neurol. 1991 Apr;48(4):410-62012516
Cites: Nucleic Acids Res. 1991 Feb 25;19(4):9682017389
Cites: J Immunol. 1991 Aug 1;147(3):1053-91861069
Cites: Nucleic Acids Res. 1991 Aug 11;19(15):43061870992
Cites: Neuropsychologia. 1992 Mar;30(3):209-271574158
Cites: Cortex. 1992 Sep;28(3):483-911395648
Cites: Arch Neurol. 1993 May;50(5):461-98489401
Cites: Am J Hum Genet. 1993 Jul;53(1):252-638317490
Cites: Diabetes. 1993 Aug;42(8):1215-88392011
Cites: Am J Hum Genet. 1993 Oct;53(4):908-158213819
Cites: Hum Hered. 1993 Nov-Dec;43(6):329-368288263
Cites: Genet Epidemiol. 1993;10(6):389-948314032
Cites: Genet Epidemiol. 1993;10(6):395-4008314033
Cites: Science. 1994 Oct 14;266(5183):276-97939663
Cites: Am J Hum Genet. 1995 Aug;57(2):487-987668275
Cites: Nature. 1996 Mar 14;380(6570):152-48600387
Cites: Genomics. 1996 Apr 1;33(1):1-88617492
Cites: Am J Hum Genet. 1996 Apr;58(4):867-808644751
Erratum In: Am J Hum Genet 1999 Jan;64(1):334
PubMed ID
9792873 View in PubMed
Less detail

Absence of the atypical mitochondrial aldehyde dehydrogenase (ALDH2) isozyme in Saskatchewan Cree Indians.

https://arctichealth.org/en/permalink/ahliterature221601
Source
Hum Hered. 1993 Mar-Apr;43(2):116-20
Publication Type
Article
Author
L E Dyck
Author Affiliation
Department of Psychiatry, University of Saskatchewan, Saskatoon, Canada.
Source
Hum Hered. 1993 Mar-Apr;43(2):116-20
Language
English
Publication Type
Article
Keywords
Alcohol Drinking - physiopathology
Aldehyde Dehydrogenase - genetics
Asia - ethnology
Asian Continental Ancestry Group - genetics
European Continental Ancestry Group - genetics
Flushing - etiology
Gene Expression Regulation, Enzymologic
Gene Frequency
Hair - enzymology
Humans
Indians, North American - genetics
Isoelectric Focusing
Isoenzymes - genetics
Mitochondria - enzymology
Phenotype
Questionnaires
Saskatchewan
Skin Tests
Abstract
Three methods were employed to assess whether human volunteers (Caucasian, Asian or Cree Indian) possessed the typical or atypical mitochondrial aldehyde dehydrogenase (ALDH2) isozyme. These methods were: (1) questioning individuals about facial flushing responses following alcohol consumption; (2) application of the ethanol skin patch test, and (3) direct analysis using isoelectric focusing and activity staining of ALDH activity in hair root samples. The results from the three methods were in good agreement and revealed that only the typical ALDH2 isozyme was expressed in Saskatchewan Cree Indians. In agreement with previous reports, the typical ALDH2 was expressed in the Caucasian group of subjects, while both the typical and atypical forms were expressed in the Asian subjects.
PubMed ID
8359813 View in PubMed
Less detail

ACTN3 R577X and other polymorphisms are not associated with elite endurance athlete status in the Genathlete study.

https://arctichealth.org/en/permalink/ahliterature140771
Source
J Sports Sci. 2010 Oct;28(12):1355-9
Publication Type
Article
Date
Oct-2010
Author
Frank E Döring
Simone Onur
Ulf Geisen
Marcel R Boulay
Louis Pérusse
Tuomo Rankinen
Rainer Rauramaa
Bernd Wolfahrt
C. Bouchard
Author Affiliation
Institute of Human Nutrition and Food Science, Christian-Albrechts-University Kiel, Kiel, Germany. vgoyrgoy@phyed.duth.gr
Source
J Sports Sci. 2010 Oct;28(12):1355-9
Date
Oct-2010
Language
English
Publication Type
Article
Keywords
Actinin - genetics
Athletes
Athletic Performance
European Continental Ancestry Group - genetics
Finland
Gene Frequency
Genotype
Germany
Homozygote
Humans
Male
North America
Odds Ratio
Physical Endurance - genetics
Polymorphism, Single Nucleotide
Abstract
Homozygosity for a premature stop codon at amino acid position 577 in the alpha-actinin-3 (ACTN3) gene leads to a-actinin-3 deficiency. This genotype is observed in approximately 18% of Caucasians. The ACTN3 R577X polymorphism has been previously associated with indicators of physical performance in several, but not all, studies. We examined the prevalence of R577X (rs1815739) and two additional haplotype tagging single nucleotide polymorphisms (htSNPs) of the ACTN3 gene (rs1791690 and rs2275998) in the Genathlete study comprising 316 male elite endurance athletes (VO2max 79.0+3.5 ml · kg(-1) · min(-1); mean +/- s) from North America, Finland, and Germany and 304 sedentary controls (VO2max 40.1+7.0 ml · kg(-1) · min(-1) matched by country of origin. The distribution of genotype and allele frequencies between the two groups was tested by Pearson chi-square and/or Fischer exact test. The prevalence of the 577X homozygote genotype was similar in endurance athletes and controls (20% and 17.5%, respectively). The resulting odds ratio for endurance performance in 577X homozygotes compared with 577R-allele carriers was 1.24 (95%CI 0.82-1.87, P = 0.3). The genotype distribution of the two htSNPs and haplotype frequencies did not differ significantly between athletes and controls. In conclusion, our findings indicate that ACTN3 R577X and other SNPs in ACTN3 are not genetic determinants of endurance performance in Caucasian males.
PubMed ID
20845221 View in PubMed
Less detail

Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood.

https://arctichealth.org/en/permalink/ahliterature6751
Source
JAMA. 2001 Mar 14;285(10):1316-21
Publication Type
Article
Date
Mar-14-2001
Author
A. Koch
M. Melbye
P. Sørensen
P. Homøe
H O Madsen
K. Mølbak
C H Hansen
L H Andersen
G W Hahn
P. Garred
Author Affiliation
Department of Epidemiology Research, Statens Serum Institut, Artillerivej 5, DK-2300 Copenhagen S, Denmark. ako@ssi.dk
Source
JAMA. 2001 Mar 14;285(10):1316-21
Date
Mar-14-2001
Language
English
Publication Type
Article
Keywords
Acute Disease
Alleles
Asian Continental Ancestry Group - genetics
Carrier Proteins - blood - genetics
European Continental Ancestry Group - genetics
Female
Genotype
Greenland - epidemiology
Humans
Infant
Inuits - genetics
Male
Mannose-Binding Lectins
Prospective Studies
Research Support, Non-U.S. Gov't
Respiratory Tract Infections - blood - epidemiology
Risk factors
Abstract
CONTEXT: Hospital-based studies have found that increased susceptibility to certain infections is associated with low serum levels of mannose-binding lectin (MBL) due to MBL variant alleles. However, the contribution of MBL insufficiency to incidence of common childhood infections at a population level is unknown. OBJECTIVE: To investigate the effect of MBL insufficiency on risk for acute respiratory tract infection (ARI) in unselected children younger than 2 years. DESIGN AND SETTING: Population-based, prospective, cohort study conducted in Sisimiut, Greenland. PARTICIPANTS: Two hundred fifty-two children younger than 2 years who were followed up weekly between August 1996 and August 1998 for morbidity surveillance. MAIN OUTCOME MEASURE: Risk of ARI, based on medical history and clinical examination, compared by MBL genotype, determined from blood samples based on presence of structural and promoter alleles. RESULTS: A 2.08-fold (95% confidence interval [CI], 1.41-3.06) increased relative risk (RR) of ARI was found in MBL-insufficient children (n = 13) compared with MBL-sufficient children (n = 239; P
Notes
Comment In: JAMA. 2001 Mar 14;285(10):1348-911255392
PubMed ID
11255386 View in PubMed
Less detail

Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjögren's syndrome.

https://arctichealth.org/en/permalink/ahliterature90739
Source
Genes Immun. 2009 Jan;10(1):68-76
Publication Type
Article
Date
Jan-2009
Author
Nordmark G.
Kristjansdottir G.
Theander E.
Eriksson P.
Brun J G
Wang C.
Padyukov L.
Truedsson L.
Alm G.
Eloranta M-L
Jonsson R.
Rönnblom L.
Syvänen A-C
Author Affiliation
Section of Rheumatology, Uppsala University, Uppsala, Sweden. Gunnel.Nordmark@medsci.uu.se
Source
Genes Immun. 2009 Jan;10(1):68-76
Date
Jan-2009
Language
English
Publication Type
Article
Keywords
Aged
Alleles
Asian Continental Ancestry Group - genetics - statistics & numerical data
Case-Control Studies
Cohort Studies
Confidence Intervals
European Continental Ancestry Group - genetics - statistics & numerical data
Female
Gene Frequency
Haplotypes
Heterozygote
Humans
Interferon Regulatory Factors - genetics - immunology
Linear Models
Linkage Disequilibrium
Male
Middle Aged
Norway
Odds Ratio
Polymorphism, Genetic
Polymorphism, Single Nucleotide
Probability
Risk factors
STAT4 Transcription Factor - genetics - immunology
Sjogren's Syndrome - genetics - immunology
Sweden
Abstract
Primary Sj?gren's syndrome (SS) shares many features with systemic lupus erythematosus (SLE). Here we investigated the association of the three major polymorphisms in IRF5 and STAT4 found to be associated with SLE, in patients from Sweden and Norway with primary SS. These polymorphisms are a 5-bp CGGGG indel in the promoter of IRF5, the single nucleotide polymorphism (SNP) rs10488631 downstream of IRF5 and the STAT4 SNP rs7582694, which tags the major risk haplotype of STAT4. We observed strong signals for association between all three polymorphisms and primary SS, with odds ratios (ORs) >1.4 and P-values
PubMed ID
19092842 View in PubMed
Less detail

Adiponectin polymorphisms, adiposity and insulin metabolism: HERITAGE family study and Oulu diabetic study.

https://arctichealth.org/en/permalink/ahliterature47016
Source
Ann Med. 2005;37(2):141-50
Publication Type
Article
Date
2005
Author
Olavi Ukkola
Merja Santaniemi
Tuomo Rankinen
Arthur S Leon
James S Skinner
Jack H Wilmore
D C Rao
Richard Bergman
Y Antero Kesäniemi
Claude Bouchard
Author Affiliation
Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge 70808-4124, USA.
Source
Ann Med. 2005;37(2):141-50
Date
2005
Language
English
Publication Type
Article
Keywords
Adipocytes - metabolism
Adiponectin
Adipose Tissue - metabolism
African Continental Ancestry Group - genetics
Case-Control Studies
Diabetes Mellitus, Type 2 - genetics
European Continental Ancestry Group - genetics
Female
Finland
Gene Frequency
Haplotypes
Histidine
Humans
Insulin - metabolism
Intercellular Signaling Peptides and Proteins - genetics
Male
Middle Aged
Polymorphism, Genetic
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Risk factors
Tyrosine
Abstract
AIMS/HYPOTHESIS: Adiponectin is an adipocytokine with lowered blood levels in obesity and Type 2 diabetes mellitus. We sought to define the specific effects of different alleles of the gene encoding adiponectin. METHODS: We studied the associations of adiponectin gene sequence variations with body fat distribution and insulin indices in 503 White and 276 Black subjects of the HERITAGE Family Study cohort and subjects from a Finnish population. RESULTS: The His111 allele frequency of the Tyr111 His polymorphism in Finnish Type 2 diabetic subjects (n=254) was higher (5.1%) than in control subjects (n=270) (2.6%; P = 0.033). In the HERITAGE cohort, the His111 allele was associated with a lower insulin sensitivity index (P = 0.018) and a higher acute insulin response to glucose (P = 0.0098) in Whites. Other variants showed associations with adiposity and plasma lipid values only in Blacks. Among Blacks, the IVS2+G62T variant was associated with body fat (P = 0.002) and total cholesterol values (P = 0.005), and the Gly15Gly variant with cholesterol (P = 0.009) and triglyceride (P = 0.05) levels. The haplotype derived from these two polymorphisms was associated with total body fat, while the IVS2+G62T and Tyr111His-haplotype was associated with body fat and disposition index. CONCLUSIONS: The carriers of the His111 allele may have a higher risk of developing Type 2 diabetes mellitus. Racial differences were found between Blacks and Whites in body composition and lipids according to ACDC genotypes. Sequence variants in the adiponectin gene appear to be associated with diabetes and diabetes-related phenotypes.
PubMed ID
16028335 View in PubMed
Less detail

Adiponectin receptor 1 gene (ADIPOR1) variant is associated with advanced age-related macular degeneration in Finnish population.

https://arctichealth.org/en/permalink/ahliterature126460
Source
Neurosci Lett. 2012 Apr 4;513(2):233-7
Publication Type
Article
Date
Apr-4-2012
Author
Kai Kaarniranta
Jussi Paananen
Tanja Nevalainen
Iiris Sorri
Sanna Seitsonen
Ilkka Immonen
Antero Salminen
Leena Pulkkinen
Matti Uusitupa
Author Affiliation
Department of Ophthalmology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland; Department of Ophthalmology, Kuopio University Hospital, Kuopio, Finland.
Source
Neurosci Lett. 2012 Apr 4;513(2):233-7
Date
Apr-4-2012
Language
English
Publication Type
Article
Keywords
Aged
Aged, 80 and over
Alleles
European Continental Ancestry Group - genetics
Female
Finland
Gene Frequency
Genetic Association Studies
Genetic Predisposition to Disease
Genotype
Humans
Macular Degeneration - genetics
Male
Polymorphism, Single Nucleotide
Receptors, Adiponectin - genetics
Abstract
Adiponectin is an adipocyte-expressed protein that regulates the glucose, lipid, and energy metabolism via adiponectin receptors 1 and 2. Obesity is a known risk factor for age-related macular degeneration (AMD). We, therefore, examined associations of single nucleotide polymorphisms in Adiponectin (ADIPOQ) and Adiponectin receptors 1 and 2 (ADIPOR1 and ADIPOR2) genes with the prevalence of advanced AMD in Finnish population. Thirty-seven markers for ADIPOQ, ADIPOR1 and ADIPOR2 were genotyped in a sample collection of 91 men and 177 women having exudative AMD and 18 men and 26 women having severe atrophic AMD. Patients were diagnosed by fundus photographs and fluorescein angiography. The control group (no signs of AMD in fundus photographs) consisted of 55 men and 111 women. Inclusion criteria age was over 65 years old without diabetes diagnosis. Out of the tested SNPs, rs10753929 located in intron of ADIPOR1 gene was significantly associated (p=0.0471) with AMD status when using a permutation procedure that controlled for the number of tested genotypes and genetic models. Odds ratio (OR) for the association was 1.699 (95% CI 1.192-2.423). The SNP consists of C/T alleles and the risk allele T had a minor allele frequency (MAF) of 20.4%. Distribution of proportion of cases/controls between alleles revealed an additive genetic model. Our findings reveal that rs10753929 ADIPOR1 variant is a novel candidate for AMD genetic risk factor in Finnish population.
PubMed ID
22387454 View in PubMed
Less detail

Admixture mapping identifies a locus on 6q25 associated with breast cancer risk in US Latinas.

https://arctichealth.org/en/permalink/ahliterature128155
Source
Hum Mol Genet. 2012 Apr 15;21(8):1907-17
Publication Type
Article
Date
Apr-15-2012
Author
Laura Fejerman
Gary K Chen
Celeste Eng
Scott Huntsman
Donglei Hu
Amy Williams
Bogdan Pasaniuc
Esther M John
Marc Via
Christopher Gignoux
Sue Ingles
Kristine R Monroe
Laurence N Kolonel
Gabriela Torres-Mejía
Eliseo J Pérez-Stable
Esteban González Burchard
Brian E Henderson
Christopher A Haiman
Elad Ziv
Author Affiliation
Department of Medicine, Division of General Internal Medicine, Institute for Human Genetics and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94158, USA.
Source
Hum Mol Genet. 2012 Apr 15;21(8):1907-17
Date
Apr-15-2012
Language
English
Publication Type
Article
Keywords
Breast Neoplasms - classification - genetics
Case-Control Studies
Chromosome Mapping
Chromosomes, Human, Pair 11 - genetics
Chromosomes, Human, Pair 6 - genetics
Estrogen Receptor alpha - genetics
European Continental Ancestry Group - genetics
Female
Gene Frequency
Genetic Loci
Genetic Predisposition to Disease
Genome-Wide Association Study
Genotype
Hispanic Americans - genetics
Humans
Microfilament Proteins - genetics
Polymorphism, Single Nucleotide
Risk factors
Abstract
Among US Latinas and Mexican women, those with higher European ancestry have increased risk of breast cancer. We combined an admixture mapping and genome-wide association mapping approach to search for genomic regions that may explain this observation. Latina women with breast cancer (n= 1497) and Latina controls (n= 1272) were genotyped using Affymetrix and Illumina arrays. We inferred locus-specific genetic ancestry and compared the ancestry between cases and controls. We also performed single nucleotide polymorphism (SNP) association analyses in regions of interest. Correction for multiple-hypothesis testing was conducted using permutations (P(corrected)). We identified one region where genetic ancestry was significantly associated with breast cancer risk: 6q25 [odds ratio (OR) per Indigenous American chromosome 0.75, 95% confidence interval (CI): 0.65-0.85, P= 1.1 × 10(-5), P(corrected)= 0.02]. A second region on 11p15 showed a trend towards association (OR per Indigenous American chromosome 0.77, 95% CI: 0.68-0.87, P= 4.3 × 10(-5), P(corrected)= 0.08). In both regions, breast cancer risk decreased with higher Indigenous American ancestry in concordance with observations made on global ancestry. The peak of the 6q25 signal includes the estrogen receptor 1 (ESR1) gene and 5' region, a locus previously implicated in breast cancer. Genome-wide association analysis found that a multi-SNP model explained the admixture signal in both regions. Our results confirm that the association between genetic ancestry and breast cancer risk in US Latinas is partly due to genetic differences between populations of European and Indigenous Americans origin. Fine-mapping within the 6q25 and possibly the 11p15 loci will lead to the discovery of the biologically functional variant/s behind this association.
Notes
Cites: Am J Respir Crit Care Med. 2004 Feb 1;169(3):386-9214617512
Cites: Genetics. 2000 Jun;155(2):945-5910835412
Cites: Am J Hum Genet. 2004 Nov;75(5):771-8915386213
Cites: Ann Intern Med. 1990 Feb 1;112(3):182-62297194
Cites: Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2905-1316365008
Cites: JAMA. 2006 Jun 7;295(21):2492-50216757721
Cites: Am J Hum Genet. 2006 Jul;79(1):1-1216773560
Cites: Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14068-7316945910
Cites: Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1878-8517035394
Cites: Am J Hum Genet. 2007 Apr;80(4):716-2617357077
Cites: Nat Genet. 2007 May;39(5):638-4417401364
Cites: Cancer. 2007 May 1;109(9):1721-817387718
Cites: Nat Genet. 2007 Jul;39(7):870-417529973
Cites: Nature. 2007 Jun 28;447(7148):1087-9317529967
Cites: Am J Epidemiol. 2007 Dec 15;166(12):1409-1917934201
Cites: Am J Epidemiol. 2000 Feb 15;151(4):346-5710695593
Cites: Nat Genet. 2007 Jul;39(7):865-917529974
Cites: Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3422-711904404
Cites: Cancer Causes Control. 2002 May;13(4):325-3212074502
Cites: Oncogene. 2002 Sep 12;21(41):6387-9412214280
Cites: Cancer Causes Control. 2002 Oct;13(8):741-5112420953
Cites: Obes Rev. 2003 Aug;4(3):157-7312916817
Cites: Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1143-5214652273
Cites: JAMA. 2007 Dec 26;298(24):2869-7618159056
Cites: Am J Hum Genet. 2008 Jan;82(1):81-718179887
Cites: Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4340-518326623
Cites: PLoS Genet. 2007 Nov;3(11):e19618020707
Cites: Genome Res. 2008 Apr;18(4):668-7518353809
Cites: Breast Cancer Res Treat. 2008 May;109(1):123-3917578664
Cites: Nat Genet. 2008 Jun;40(6):703-618438407
Cites: Nat Genet. 2008 Oct;40(10):1185-9218794854
Cites: Nat Genet. 2008 Oct;40(10):1175-8418794856
Cites: Cancer Res. 2008 Dec 1;68(23):9723-819047150
Cites: PLoS Genet. 2009 Jan;5(1):e100036019180233
Cites: Am J Hum Genet. 2009 Feb;84(2):210-2319200528
Cites: Nat Genet. 2009 Mar;41(3):324-819219042
Cites: Nat Genet. 2009 May;41(5):585-9019330027
Cites: Nat Genet. 2009 May;41(5):579-8419330030
Cites: PLoS Genet. 2009 May;5(5):e100049019461885
Cites: Bioinformatics. 2009 Jun 15;25(12):i213-2119477991
Cites: PLoS Genet. 2009 Jun;5(6):e100051919543370
Cites: PLoS Genet. 2009 Aug;5(8):e100059719680443
Cites: PLoS Biol. 2010 Jan;8(1):e100029420126254
Cites: Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):1074-8220332279
Cites: Nat Genet. 2010 Jun;42(6):504-720453838
Cites: PLoS Genet. 2010 Jun;6(6):e100100220585626
Cites: Nature. 2010 Jul 8;466(7303):238-4220531471
Cites: PLoS Genet. 2010 Jul;6(7):e100102920661439
Cites: Science. 2010 Aug 13;329(5993):841-520647424
Cites: Hum Genet. 2010 Sep;128(3):345-5020635188
Cites: Annu Rev Genomics Hum Genet. 2010;11:65-8920594047
Cites: CA Cancer J Clin. 2010 Sep-Oct;60(5):277-30020610543
Cites: Cancer Res. 2011 Feb 15;71(4):1344-5521303983
Cites: J Natl Cancer Inst. 2011 Mar 2;103(5):425-3521263130
Cites: PLoS Genet. 2011 Apr;7(4):e100138221552322
Cites: Breast Cancer Res. 2004;6(4):R375-8915217505
PubMed ID
22228098 View in PubMed
Less detail

511 records – page 1 of 52.